![Teva reúne a más de 450 expertos en Neurología en la XIII reunión de Post-ECTRIMS y la V de SINÁPTICA, los mayores encuentros sobre enfermedades del sistema nervioso central en nuestro país - Teva reúne a más de 450 expertos en Neurología en la XIII reunión de Post-ECTRIMS y la V de SINÁPTICA, los mayores encuentros sobre enfermedades del sistema nervioso central en nuestro país -](https://www.farmaventas.es/images/fnot/Teva-logo.jpg)
Teva reúne a más de 450 expertos en Neurología en la XIII reunión de Post-ECTRIMS y la V de SINÁPTICA, los mayores encuentros sobre enfermedades del sistema nervioso central en nuestro país -
![Uninhibited' price hikes, lobbying and more: Congressional probe gives detailed look into Teva's long run with Copaxone | Fierce Pharma Uninhibited' price hikes, lobbying and more: Congressional probe gives detailed look into Teva's long run with Copaxone | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1601469710/Copaxone.jpg/Copaxone.jpg?VersionId=PhbA.kpjNFb3A_uch5krsTbbBmdM_mNL)
Uninhibited' price hikes, lobbying and more: Congressional probe gives detailed look into Teva's long run with Copaxone | Fierce Pharma
Teva Pharma on Twitter: "Comienza #SINAPTICA, mayor foro de encuentro de expertos en #Neurología de España, organizado por Teva Neuroscience https://t.co/8DdcsQpPaX" / Twitter
![Laquinimod, an Oral Product in Development for the Treatment of Relapsing Remitting Multiple Sclerosis Steve Glenski, PharmD Medical Affairs Teva Neuroscience. - ppt download Laquinimod, an Oral Product in Development for the Treatment of Relapsing Remitting Multiple Sclerosis Steve Glenski, PharmD Medical Affairs Teva Neuroscience. - ppt download](https://slideplayer.com/10609964/36/images/slide_1.jpg)
Laquinimod, an Oral Product in Development for the Treatment of Relapsing Remitting Multiple Sclerosis Steve Glenski, PharmD Medical Affairs Teva Neuroscience. - ppt download
Jeffrey McClard - Sr. Director, Institutional & Oncology GPO's, Market Access, Teva Neuroscience - Teva Pharmaceuticals | LinkedIn
![Teva to Present New Data from Growing Mental Health Portfolio at Psych Congress 2021 | Business Wire Teva to Present New Data from Growing Mental Health Portfolio at Psych Congress 2021 | Business Wire](https://mms.businesswire.com/media/20211021005210/en/739014/22/teva_RGB_JPEG.jpg)
Teva to Present New Data from Growing Mental Health Portfolio at Psych Congress 2021 | Business Wire
![TEVA NEUROSCIENCE Trademark of Teva Pharmaceuticals USA, Inc. Serial Number: 76268515 :: Trademarkia Trademarks TEVA NEUROSCIENCE Trademark of Teva Pharmaceuticals USA, Inc. Serial Number: 76268515 :: Trademarkia Trademarks](https://mark.trademarkia.com/logo-images/teva-pharmaceuticals-usa/teva-neuroscience-76268515.jpg)